Jiang Xiaomeng: A Centennial Enterprise with Craftsman Spirit
Release time:
2020-07-31
Editor's Note: days ago, the United Front Work Department of Jinhua Municipal Committee, the Municipal Federation of Industry and Commerce and other units jointly launched a large-scale publicity campaign on "2016 Letter to Good Wu Merchants". 10# June 18 , Jinhua media reporters walked into the peak and made a collective interview with Chairman Jiang Xiaomeng. 10# October 21 , the front page of Jinhua Daily published the article "Jiang Xiaomeng: Strive for a Century of Enterprise with Craftsman Spirit" written by its reporter Zhang Shuai. This newspaper is reproduced.
58 , Chairman Jiang Xiaomeng's face is filled with passion and confidence.
58 years, the peak has experienced ups and downs. Every time it encounters a major turning point, generations of "peak people" have opened a new chapter with tireless efforts and simple wisdom.
11.03 .6 billion yuan, up 4.15% over the same period of last year; Net profit attributable to owners of the parent company reached 1.03 billion yuan, up 12.9 year on year. These data in the current weak domestic economic development, has become more prominent.
58 years, and are also the models of our "wushang" group to stick to industry, operate in good faith and serve the country by industry.
58 years ago, bearing in mind the history of the peak, can be seen at a glance by many old Jin Chinese. This is the original site of the Wisdom Temple in the north of Jinhua City. The place was small and desolate. The first group of pioneers built the first cement factory in Jinhua with their hands and blood.
20 years old, he walked into the gate of the cement factory and is now leading thousands of people to fight the business world. Jiang Xiaomeng said that this is the common growth and achievement of individuals and enterprises. 1993
28 , unusual for Jianfeng Group. On this day, Jianfeng stock started trading on the Shanghai Stock Exchange and became the country's first listed company in the cement industry, which laid the foundation for the standardized management and further development of Jianfeng Group. to 2006
2007 , the cement market competition is extremely fierce, coupled with the state's policy restrictions on the closure of mechanical vertical kilns, many cement plants have lost their competitiveness. Spikes are also facing harsh realities, and benefits are plummeting. At this key node, Jianfeng cooperated with central enterprises in a timely manner to transfer the equity of cement enterprise 65% in Zhejiang Province, set up Southern Cement, became one of the sponsors of Southern Cement, and invested limited funds in the central and western regions with more advantages in market prospects, resources and supply. After the most difficult period from 2006 to
, Jianfeng promptly established the development policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and became an industrial pattern with cement and medicine as the two main businesses, bonded logistics as the supplement, and multiple investments in concentric related industries as the supplement, which further clarified the industrial positioning of the group, be a niche in the cement market, a leader in the pharmaceutical industry segment, and a leader in health product innovation. Jiang Xiaomeng said that these decisions are strategic choices made in combination with the actual situation of the peak and the development trend, and are the self-adjustment of the peak group on the road of development. Only when the positioning is accurate and the goal is clear can an enterprise have the driving force for sustainable development.
Looking forward to the future, driven by innovation in medicine and health, the industry is booming
. Besides complementing cement and having a broad market, Jiang Xiaomeng hopes to stimulate the vitality of the peak through medicine and health.
During the peak years of
, Jiang Xiaomeng knew very well that innovation and development are the best catalysts for enterprises to maintain vitality. To be brave, transformation and upgrading are the best driving forces. The medical and health industry is also one of the most obvious industries driven by scientific and technological innovation. Jianfeng Pharmaceutical has always paid attention to the innovative research and development of pharmaceutical products. It has two professional research institutions and a provincial new drug research and development center. At the same time, it has
academician expert workstations and 3 postdoctoral mobile stations in the field of plant extracts and chemical pharmaceuticals respectively, and has obtained more than 20 national invention patents . This has laid a solid foundation for the innovation of peak pharmaceutical products. Many products of Jianfeng Pharmaceutical have been listed as national high-tech industrialization demonstration project, national key new product plan project and national torch plan project, and have been rated as national high-tech enterprises for 10 years in a row. In addition, with the deepening of the management of pharmaceutical commercial circulation order, the peak will effectively integrate the existing internal circulation enterprises in the field of circulation, and constantly improve the profitability and business model with innovative thinking, so as to make the pharmaceutical circulation enterprises more standardized, more orderly and stronger, and further enhance their competitiveness. Jianfeng Health Technology Co., Ltd. is another major layout of Jianfeng Group in the field of health in recent years. Entering the company's laboratory, high-tech experimental equipment can be seen everywhere. In front of a piece of equipment, Yu Hongjian, general manager of the Health Technology Company, told reporters that this is the first production equipment used in ginkgo extract in China. The entire production process is operated and monitored in real time by the computer system in the central control room to minimize Human errors and risks ensure stable and safe product quality. In the central control room, the reporter also saw two staff members staring at the large computer screen all the time, paying attention to the changes in the monitoring values on the screen.
In the Peak Health Experience Hall, Jiang Xiaomeng introduced that the big health industry is a very broad concept, including health care products, health care for the aged, health care, etc. With the improvement of people's living conditions, people's demand will be more and more big. The human demand for health, health care and longevity is an irreversible trend and trend. The positioning of the peak for the big health industry is: natural raw materials, ancient and modern use, changing tradition into fashion, and being a leader in health product innovation. Around this concept, Spike has done a lot of work in innovative decoction pieces and has obtained a number of patents, for example, many people know that eating Gastrodia elata is good, but the texture of Gastrodia elata is hard, how to eat it? Spike Health makes Gastrodia elata slices that dehydrate and freeze-dry slices of fresh Gastrodia elata, which is as simple and convenient as eating potato chips. There are also freeze-dried ultra-fine powder of noto-ginseng, freeze-dried Dendrobium, heart-shaped Astragalus tablets and so on.
listed
years, Jianfeng Group's total assets have increased from 1.38 .2 billion yuan at the beginning of listing to 35.78 .4 billion yuan now, and its net assets have increased from less than 1 .6 billion yuan to 22.01 .8 billion yuan, increasing nearly 26 times and 22 times respectively. operates in good faith, sticks to industry, and does not forget social responsibility
In the Jianfeng History Showroom, photos with historical accumulation make people feel that Jianfeng Group is working hard and at the same time, they also see Jianfeng's active social responsibility. Since the listing of
, the peak tax payment and social security payment have exceeded
.3 billion yuan, which has been a major taxpayer of enterprises in Jinhua for many years. Jianfeng Group, Jianfeng Pharmaceutical, Jianfeng Cement and other holding companies were rated as Zhejiang Province 3A -class contract-abiding and trustworthy units, integrity management enterprises. Jianfeng Group has just won the silver award of "Zhejiang Industry Award" in 2016 this year, and is the second batch of "three" cultivation pilot enterprises in Zhejiang Province. Jianfeng Group has also carried out fruitful work in enterprise pairing, thousand enterprise pairing, and employee labor security. It has been rated as an advanced ideological and political work unit in Zhejiang Province and Jinhua City for many years. started from
April with a donation of of 20 .56 million yuan to build "Zhejiang Jianfeng Hope Primary School" (the first Hope Primary School on the "Roof of the World" aided by an enterprise) in Nagqu District of Tibet Autonomous Region. Jianfeng Group's "Hope" road lasted for 21 years. In the meantime, 8 Hope Primary School, which was built with high-end donations, has sprung up. Its donation areas cover Tibet, Gansu, Yunnan and our Jinhua region.
.5 billion yuan in environmental protection technological transformation funds exceeding . Because ecological development has been implanted into corporate culture, many important activities can always see the figure of the peak, such as Jinhua five water co-governance, Wenchuan earthquake relief, Jinhua Red Cross donation AED automatic defibrillator and so on.
58 years, in addition to the upbringing of Jinhua, is also because the peak development has four cornerstones: a strong corporate culture, a development path suitable for itself, and an endogenous expansion desire that matches its own strength, there is a management team that highly identifies with the culture of spikes. "Our mission is to be a century-old peak, and generations of peak people will dream of the future with the spirit of craftsmen." ("Jinhua Daily" reporter Zhang Shuai)
More information
Pharmaceutical Company Established New Drug R & D Promotion Committee
Recently, the new drug research and development promotion committee of Jianfeng pharmaceutical company was formally established, which will be responsible for promoting the new drug research and development progress of pharmaceutical companies and subordinate enterprises, and coordinating the new drug research and development work of various departments and subordinate enterprises. The New Drug Promotion Committee is headed by Huang Jinlong, deputy general manager of the group and general manager of the pharmaceutical company, and Jiang Hong, deputy general manager of the pharmaceutical company, is headed by Pang Xiong, Shi Cunyuan, Xu Lizhen, Yu Jingjing, Zheng Kunwu, Feng Lixiang, Kang Litao, Li Qian, Wu Chonggui, Zhai Tsunami, Huang Fang and Tong Xiaojun. The committee has an office, and Shi Cunyuan is also the director of the office, responsible for the supervision, communication, and coordination of the company's new drug research and development projects. The main responsibilities of the new drug promotion committee include: organizing the establishment and improvement of the R & D project management system and relevant regulations of the pharmaceutical company; organizing the formulation of the development plan of the new drug R & D project of the pharmaceutical company and supervising the implementation; making decisions on project initiation and participating in project evaluation; supervising the management of new drug R & D of the pharmaceutical company and providing guidance; Responsible for the process management of new drug R & D projects and the promotion and coordination of new drug R & D; carry out the assessment of new drug research and development projects; issue the responsibility system assessment and task statement of new drug research and development projects; be responsible for solving major technical problems in the process of new drug research and development; be responsible for the research and improvement of the management mode of research and development projects of pharmaceutical companies; be responsible for the future trend analysis of new drug research and development projects; review the major scientific research achievements of pharmaceutical companies and put forward reward suggestions. Huang Jinlong said that the research and development of new drugs is an important foundation for the healthy development of the pharmaceutical industry and is a systematic project. Jianfeng Pharmaceutical has always attached great importance to the research and development of new drugs, but there is still a certain gap between the progress of research and development and the development process of the enterprise, and the lack of coordination in the research and development process also affects the progress and quality of new drug research and development to a certain extent. The purpose of the establishment of the New Drug Research and Development Promotion Committee is to solve the progress of new drug research and development, to find and solve problems in time, to implement more targeted, and to effectively integrate enterprise resources, improve the speed and quality of new drug research and development, and make good product reserves for the healthy development of pharmaceutical companies. (Reporter Ni Yingzhen)
2020
09-11
Jianfeng Pharmaceutical ranks among the top 100 Chinese pharmaceutical industries in 2019
On August 25, the "2019 Top 100 Series List of China's Pharmaceutical Industry" was released in Kunming. Zhejiang Jianfeng Pharmaceutical Company was shortlisted as one of the top 100 enterprises in China's pharmaceutical industry. The product Berunning (Olopatadine Hydrochloride Eye Drops) was selected as the "Most Growing Product Brand" of China's pharmaceutical industry ". The "Top 100 Pharmaceutical Industry Series List" was evaluated and released by Guangzhou Punctuation Pharmaceutical Information Co., Ltd., a subsidiary of the Southern Institute of Pharmaceutical Economics of the State Drug Administration, and is known as the "Oscar in Chinese Pharmaceutical Industry. Southern Institute is the earliest institution in China that specializes in pharmaceutical industry policy and market economy research, pharmaceutical market research, pharmaceutical economic data analysis and research, and pharmaceutical professional media publishing. It is in the field of market information value-added services and media communication and marketing services in China's pharmaceutical and health industry., The field of professional quality improvement has extremely extensive influence. The "Top 100 Pharmaceutical Industry" is comprehensively evaluated by the company's annual pharmaceutical industry sales revenue, total profit and R & D investment results. On the same day, the "most growing product brand" of Chinese medicine selected by the Southern Institute's media "Pharmaceutical Economic News" was released simultaneously. Spike Pharmaceuticals product Beirunning (Olopatadine Hydrochloride Eye Drops) was selected. (Xu Yuting)
2020
09-01
Company Disclosure 2020 Semi-Annual Report
On August 28, the Group held the 16th meeting of the 10th Board of Directors of the Company by means of communication, and considered and adopted the "2020 Semi-Annual Report of Jianfeng Group" and the "Proposal on Changes in the Company's Accounting Policy". On August 29, the Company's 2020 semi-annual report was publicly disclosed on the Shanghai Stock Exchange and the Shanghai Securities News and China Securities News. In the first half of the year, the Group focused on the general policy of "grasping projects, making up for shortcomings, improving quality and efficiency, and constantly improving the core competitive advantage", and on the basis of doing a good job in epidemic prevention and control, the Group seized the resumption of work and production, accelerated project construction, and enhanced the core competitiveness of enterprises. In the first half of 2020, the company achieved total operating income of 1.44 billion yuan, net profit attributable to shareholders of 0.368 billion yuan, net profit per share of 1.07 yuan. As of the end of June 2020, the Company's total assets were $5.892 billion, net assets were $4.068 billion, and net assets per share were $11.82. From February to April, affected by the epidemic, the national project construction progress slowed down, cement market demand decreased; after May, the epidemic was effectively controlled, infrastructure investment continued to recover, the real estate industry continued to pick up, cement sales steadily rebounded. During the outbreak, Daye Peak completed the technical transformation projects such as the cold machine, cement mill, into the desulfurization tower anti-corrosion transformation, to ensure the efficient operation of the production equipment after the resumption of work. Yunnan peak rotary kiln production, cement production and other major technical and economic indicators of steady rise; comply with market trends, timely adjustment of marketing policies. Guizhou Jianfeng has promoted the project infrastructure construction, equipment installation and commissioning, raw material bidding and other work in an orderly manner, and through preliminary publicity to enhance the popularity of the Jianfeng brand in the local area, and make a series of preparations for the transformation from project construction to production and operation. In the first half of 2020, the reform of China's medical and health system continued to deepen, and new policies were introduced intensively. Peak Pharmaceuticals and its subsidiaries in the epidemic prevention work at the same time in the first time to achieve the resumption of production, and actively organize donations to support the fight against the epidemic, was named the annual "war epidemic star" the most socially responsible pharmaceutical enterprises. In the first half of the year, Jianfeng Pharmaceutical continued to increase the introduction and development of varieties, and JFAN-1001 applied for clinical application of new anti-tumor drugs. At present, it has obtained the notice of approval for clinical trials. Optimize the production process of API workshop and further shorten the production cycle of raw materials. Continue to improve product sales policies and strengthen market channel control. Shanghai North Carolina further straightened out the internal management structure, production and marketing convergence more smoothly, continue to promote the construction of Anhui North Carolina and Anhui Zhongwang Phase II technical transformation project, promote the peak pharmaceutical raw materials, preparations integration of industrial upgrading strategy. Other business segments of the company actively responded to the challenge of the new crown epidemic and carried out production and operation activities in a standardized and orderly manner. Tianjin natural products company vigorously explore the international and domestic markets, sales revenue to achieve steady growth. Peak Health focuses on the basic idea of "sales orientation, burden reduction and efficiency improvement, fine-grained savings, cost reduction and efficiency enhancement" to effectively improve the operational efficiency of enterprises. Jianfeng International Trade has actively developed new storage business varieties and achieved practical results, and has become the first enterprise in Jinhua to formally obtain the qualification of "network freight. Peak cable seizes the special needs of communication cables such as subways, vigorously promotes large logarithmic cables for subways, and strives to achieve the long tail effect. On the same day, the company also held the 10th meeting of the Ninth Board of Supervisors and reviewed and approved relevant reports. (residual fruit)
2020
09-01
The company organizes new employee induction training
From August 12 to 14, in order to strengthen the training of talents in the group and improve the comprehensive quality of new employees, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, Yu Jianhong, general manager, and other leaders and heads of relevant enterprises and departments conducted a three-day induction training for new employees. New employees from foreign enterprises such as Guizhou Huangping Peak, Daye Peak and Shanghai North Carolina participated simultaneously through online methods. In the course of corporate culture, General Manager Yu Jianhong started from the history of the development and struggle of the peak, divided into five stages: hard work, determined reform, diversified development, strategic adjustment, and strategic development, and introduced in detail the development process of the group company and the current industrial layout., The results achieved; from the aspects of enterprise spirit, vision, development philosophy, values, business philosophy, etc, this paper introduces the peak corporate culture rooted in 62 years of history and inherited in the blood; from the perspective of an enterprise manager and old employees, he speaks a lot of truth to the new employees and puts forward a lot of hopes and suggestions. Chairman Jiang Xiaomeng took "How New Employees Achieve Win-Win with Enterprises" as the topic, and proposed that the key to the success of an enterprise lies in how to select, retain, educate and employ people. Peak and employees complement each other. Peak can achieve today's achievements and the struggle of generations of peak people are inseparable. He also taught new employees the basic concepts that need to be understood, the basic qualities that need to be possessed and the sense of hardship in entering the new environment through 16 key words, and combined with his own experience and quoting from others, he analyzed the core elements of success, the signs of a successful career, the personal qualities that need to be possessed for success, and the importance of establishing a personal knowledge management system, it expresses the ardent hope of new employees to adjust their mentality, keep learning, clear goals, clear dreams, cultivate win-win thinking, and grow up together with the peak. The heads of the human resources department of the group company, the safety management office of the group company, and the comprehensive department of the pharmaceutical company also taught the new employees the corporate rules and regulations and the "Employee Handbook", safety knowledge and professional ethics. The new employees also visited the group exhibition hall and had a deeper understanding of the development history and enterprise achievements of the peak. After the training, the human resources department also organized an examination to test the training effect. (Reporter Chen Shengmu)
2020
08-21
According to this newspaper, through the interconnection monitoring of the transportation department in Zhejiang province, the network freight platform of peak international trading company passed the online service capability audit, interface access audit, eight capability identification and other audit procedures, and successfully obtained the road transportation business license with the qualification of "network freight" on July 2. It is understood that Jianfeng International Trade is currently the first enterprise in Jinhua and Quzhou to obtain this qualification.
2020
08-05
News from our newspaper On July 21, Xi Jinping, General Secretary of the Central Committee of the Communist Party of China, President of the State, and Chairman of the Central Military Commission hosted a symposium for entrepreneurs in Beijing and delivered an important speech. Over the past few days, the General Secretary's speech has aroused strong repercussions in all walks of life. On July 23, Jiang Xiaomeng, chairman of the group company, said in an interview with Jinhua TV that the general secretary's speech was calm and inspiring, and pointed out the direction of future work for entrepreneurs.
2020
08-05
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page